User:Macowell/Part Documentation Guidelines

From 2007.igem.org

(Difference between revisions)
m (Part Design page)
Line 23: Line 23:
* '''9''' Pitfalls – designs that didn't work, revisions necessary, or an explicit statement that everything worked as planned
* '''9''' Pitfalls – designs that didn't work, revisions necessary, or an explicit statement that everything worked as planned
* '''10''' MTAs, patents - Significant IP? Do we want an explicit answer?  Really? (we should make the heading automatically link to the disclaimer page about IP & iGEM issues)
* '''10''' MTAs, patents - Significant IP? Do we want an explicit answer?  Really? (we should make the heading automatically link to the disclaimer page about IP & iGEM issues)
 +
 +
== User Experience Page ==
* '''11''' Experience - explicitly state how the part worked in your lab; provide any available experimental details generated from testing the part (including uploading data files to the registry wiki)
* '''11''' Experience - explicitly state how the part worked in your lab; provide any available experimental details generated from testing the part (including uploading data files to the registry wiki)

Revision as of 18:40, 6 August 2007

This is a draft of the part documentation guidelines used to evaluate parts Submitted for Acceptance. We want every part to have a paragraph or more of text on the main page, preferably with a diagram (but not necessarily), that clearly answers the questions posed in 2.1, 2.2, and 2.3 of the guidelines.

Contents

Part Main page

  • 1 Part title
  • 2 Abstract
    • 2.1 What is it needed for? Function.
    • 2.2 How does it work
    • 2.3 How do you use it?
  • 3 Dependencies (other parts, chemicals, strains) (explicitly stated)
  • 4 Subparts figure
  • 5 Diagram is encouraged

Part Design page

  • 6 How did you build it? What you would need to know if you wanted to re-create the part? For instance, include as warranted info about:
    • Primers used if DNA was PCRed out of a natural system
    • Mutagenesis performed (i.e. for standards compliance)
    • Codon optimization
    • Removal or addition Biobrick cloning sites
    • Synthesis details, if DNA synthesized
  • 7 Source of part material - i.e. where did the provided sequence in Hard Info come from? If in online database, provide accession no. else provide pertinent info about the sequencing run (perhaps links to sequence read files, uploaded to registry?)
    • 7.1 organism;
    • 7.2 sequence source database & accession number
  • 8 References (at least 2 – if not, justify it and provide links to the other resources used - i.e. online open-access textbook, OWW page, etc.)
  • 9 Pitfalls – designs that didn't work, revisions necessary, or an explicit statement that everything worked as planned
  • 10 MTAs, patents - Significant IP? Do we want an explicit answer? Really? (we should make the heading automatically link to the disclaimer page about IP & iGEM issues)

User Experience Page

  • 11 Experience - explicitly state how the part worked in your lab; provide any available experimental details generated from testing the part (including uploading data files to the registry wiki)

Hard Info

  • 12.1 Sequence
  • 12.2 Significant features - If any of the features from the features list is mentioned/talked about in your part description, make sure that it is part of the sequence and features